Patients who have Alzheimer's disease who used antiepileptics had an increased number of accumulated hospital days than patients with Alzheimer's disease who didn't use antiepileptics, according to a new study from the University of Eastern Finland. The results were published in the Journal of American Medical Directors Association.
During a two-year follow-up, persons who initiated antiepileptic drugs accumulated approximately eight more hospital days per person-year. Up to 1% of the population needs long-term use of antiepileptic drugs to control their epilepsy.
Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death.
Advertisement
‘The risk-benefit analysis should be done on the usage of antiepileptic drugs in old adults especially in those with Alzheimer's disease.’
Read More..
Tweet it Now
Read More..
Other indications for antiepileptic drugs include neuropathic pain, as well as behavioural and psychological symptoms of dementia in persons with Alzheimer's disease. Therefore, the study was restricted to persons without an epilepsy diagnosis.
Despite this, differences in the accumulated number of hospital days between antiepileptic users and nonusers were most evident for musculoskeletal, respiratory and neurological diseases (excluding Alzheimer's disease), and mental and behavioural disorders (excluding dementia). However, dementia was the most common diagnosis for hospitalisations.
All-cause hospitalisations have been suggested to proxy overall drug safety, and therefore the results may partially reflect adverse effects. However, the results likely also reflect the treatment of neuropathic pain or behavioural and psychological symptoms of dementia.
Because of problems in communication, diagnosis of neuropathic pain is extremely demanding and the risk of incorrect diagnosis in this population is high. Because untreated pain can manifest as behavioural and psychological symptoms, such as aggression, its identification and treatment are important. The findings highlight the importance of future studies on the risk-benefit ratio of antiepileptic drugs in old adults and especially in those with Alzheimer's disease.
The studies were based on the nationwide register-based MEDALZ cohort that includes all community-dwelling persons with clinically verified diagnosis of Alzheimer's disease in Finland during 2005-2011 (70,718 people).
Data on antiepileptic drug use was extracted from the Finnish Prescription Register. Comorbidities, concomitant medications and time since AD diagnosis were accounted in the analyses. The study was conducted at the University of Eastern Finland and funded by the Academy of Finland.
Source: Eurekalert
Advertisement
All-cause hospitalisations have been suggested to proxy overall drug safety, and therefore the results may partially reflect adverse effects. However, the results likely also reflect the treatment of neuropathic pain or behavioural and psychological symptoms of dementia.
Because of problems in communication, diagnosis of neuropathic pain is extremely demanding and the risk of incorrect diagnosis in this population is high. Because untreated pain can manifest as behavioural and psychological symptoms, such as aggression, its identification and treatment are important. The findings highlight the importance of future studies on the risk-benefit ratio of antiepileptic drugs in old adults and especially in those with Alzheimer's disease.
The studies were based on the nationwide register-based MEDALZ cohort that includes all community-dwelling persons with clinically verified diagnosis of Alzheimer's disease in Finland during 2005-2011 (70,718 people).
Data on antiepileptic drug use was extracted from the Finnish Prescription Register. Comorbidities, concomitant medications and time since AD diagnosis were accounted in the analyses. The study was conducted at the University of Eastern Finland and funded by the Academy of Finland.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
